絞り込み

16506

広告

Afatinib treatment of a squamous lung cancer after tumor progression of nivolumab.

著者 Jin Y , Jiang Q , Xin T
Thorac Cancer.2017 Oct 13 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (134view , 0users)

Full Text Sources

Nivolumab prolonged disease control in a patient with advanced squamous lung cancer that was refractory to multiple treatments. The rapid eradication of cancer after the administration of nivolumab caused hemoptysis and repeated infection. Six months after immunotherapy, mediastinal lymph node metastasis developed and afatinib effectively relieved dysphonia associated with nerve paralysis.
PMID: 29027754 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード